Breakthrough COVID treatment may stop ‘100% of symptomatic infections’

The makers of an experimental drug, now being trialled by the NHS, say it is 100 per cent effective in protecting against symptomatic cases of the virus.

US-based Regeneron Pharmaceuticals says its two-antibody cocktail called REGEN-COV also reduces overall coronavirus infection rates by about 50 per cent.

The claims are based on interim results and the “confirmatory stage”
Read more…

Please follow and like us: